DSC MR Perfusion at 7T MRI: An Initial Single-Center Study for Validity and Practicability

References

1. 1.↵
   1. Welker K,
   2. Boxerman J,
   3. Kalnin A, et al

   ; American Society of Functional Neuroradiology MR Perfusion Standards and Practice Subcommittee of the ASFNR Clinical Practice Committee. ASFNR recommendations for clinical performance of MR dynamic susceptibility contrast perfusion imaging of the brain. AJNR Am J Neuroradiol 2015;36:E41–51 doi:10.3174/ajnr.A4341 pmid:25907520

   Abstract/FREE Full Text
2. 2.↵
   1. Barajas RF,
   2. Chang JS,
   3. Sneed PK, et al

   . Distinguishing recurrent intra-axial metastatic tumor from radiation necrosis following gamma knife radiosurgery using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol 2009;30:367–72 doi:10.3174/ajnr.A1362 pmid:19022867

   Abstract/FREE Full Text
3. 3.↵
   1. Hiremath SB,
   2. Muraleedharan A,
   3. Kumar S, et al

   . Combining diffusion tensor metrics and DSC perfusion imaging: can it improve the diagnostic accuracy in differentiating tumefactive demyelination from high-grade glioma? AJNR Am J Neuroradiol 2017;38:685–90 doi:10.3174/ajnr.A5089 pmid:28209583

   Abstract/FREE Full Text
4. 4.↵
   1. Wintermark M,
   2. Sanelli PC,
   3. Albers GW, et al

   . Imaging recommendations for acute stroke and transient ischemic attack patients: a joint statement by the American Society of Neuroradiology, the American College of Radiology, and the Society of NeuroInterventional Surgery. AJNR Am J Neuroradiol 2013;34:E117–27 doi:10.3174/ajnr.A3690 pmid:23907247

   Abstract/FREE Full Text
5. 5.↵
   1. Apruzzese A,
   2. Silvestrini M,
   3. Floris R, et al

   . Cerebral hemodynamics in asymptomatic patients with internal carotid artery occlusion: a dynamic susceptibility contrast MR and transcranial Doppler study. AJNR Am J Neuroradiol 2001;22:1062–67 pmid:11415898

   PubMedWeb of Science
6. 6.↵
   1. Barajas RF, Jr.,
   2. Chang JS,
   3. Segal MR, et al

   . Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 2009;253:486–96 doi:10.1148/radiol.2532090007 pmid:19789240

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Essig M,
   2. Nguyen TB,
   3. Shiroishi MS, et al

   . Perfusion MRI: the five most frequently asked clinical questions. AJR Am J Roentgenol 2013;201:W495–510 doi:10.2214/AJR.12.9544 pmid:23971482

   CrossRefPubMed
8. 8.↵
   1. Petrella JR,
   2. Provenzale JM

   . MR perfusion imaging of the brain: techniques and applications. AJR Am J Roentgenol 2000;175:207–19 doi:10.2214/ajr.175.1.1750207 pmid:10882275

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Copen WA,
   2. Schaefer PW,
   3. Wu O

   . MR perfusion imaging in acute ischemic stroke. Neuroimaging Clin N Am 2011;21:259–83 doi:10.1016/j.nic.2011.02.007 pmid:21640299

   CrossRefPubMed
10. 10.↵
    1. Gordaliza PM,
    2. Mateos-Perez JM,
    3. Montesinos P, et al

    . Development and validation of an open source quantification tool for DSC-MRI studies. Comput Biol Med 2015;58:56–62 doi:10.1016/j.compbiomed.2015.01.002 pmid:25618215

    CrossRefPubMed
11. 11.↵
    1. Knutsson L,
    2. Xu X,
    3. Stahlberg F, et al

    . Dynamic susceptibility contrast MRI at 7 T: tail-scaling analysis and inferences about field strength dependence. Tomography 2017;3:74–78 doi:10.18383/j.tom.2017.00001 pmid:28825038

    CrossRefPubMed
12. 12.↵
    1. Ozutemiz C,
    2. White M,
    3. Elvendahl W, et al

    . Use of a commercial 7-T MRI scanner for clinical brain imaging: indications, protocols, challenges, and solutions-a single-center experience. AJR Am J Roentgenol 2023;221:788–804 doi:10.2214/AJR.23.29342 pmid:37377363

    CrossRefPubMed
13. 13.↵
    1. Elschot EP,
    2. Backes WH,
    3. van den Kerkhof M, et al

    . Cerebral microvascular perfusion assessed in elderly adults by spin-echo dynamic susceptibility contrast MRI at 7 Tesla. Tomography 2024;10:181–92 doi:10.3390/tomography10010014 pmid:38250960

    CrossRefPubMed
14. 14.↵
    1. Wongsawaeng D,
    2. Schwartz D,
    3. Li X, et al

    . Comparison of dynamic susceptibility contrast (DSC) using gadolinium and iron-based contrast agents in high-grade glioma at high-field MRI. Neuroradiol J 2024;37:473–82 doi:10.1177/19714009241242596 pmid:38544404

    CrossRefPubMed
15. 15.↵
    1. Fagan AJ,
    2. Bitz AK,
    3. Bjorkman-Burtscher IM, et al

    ; ISMRM Safety Committee. 7T MR safety. J Magn Reson Imaging 2021;53:333–46 doi:10.1002/jmri.27319 pmid:32830900

    CrossRefPubMed
16. 16.↵
    1. Teeuwisse WM,
    2. Brink WM,
    3. Haines KN, et al

    . Simulations of high permittivity materials for 7 T neuroimaging and evaluation of a new barium titanate-based dielectric. Magn Reson Med 2012;67:912–18 doi:10.1002/mrm.24176 pmid:22287360

    CrossRefPubMed
17. 17.↵
    1. Teeuwisse WM,
    2. Brink WM,
    3. Webb AG

    . Quantitative assessment of the effects of high-permittivity pads in 7 Tesla MRI of the brain. Magn Reson Med 2012;67:1285–93 doi:10.1002/mrm.23108 pmid:21826732

    CrossRefPubMed